Inovio Pharmaceuticals, Inc. (INO)

USD 1.92

(1.59%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 172.94 Million 348.53 Million 495.94 Million 539.77 Million 143.95 Million 131.11 Million
Total Current Assets 153.11 Million 315.24 Million 448.44 Million 471.17 Million 94.2 Million 87.81 Million
Cash And Short Term Investments 145.29 Million 252.99 Million 401.31 Million 411.64 Million 89.53 Million 81.23 Million
Cash and Cash Equivalents 14.31 Million 46.32 Million 71.14 Million 250.72 Million 22.19 Million 23.69 Million
Short Term Investments 130.98 Million 206.66 Million 330.17 Million 160.91 Million 67.33 Million 57.53 Million
Net Receivables 2.4 Million 11.73 Million 8.03 Million 19.06 Million 2.03 Million 4.05 Million
Inventory - - - - - -
Other Current Assets 5.41 Million 50.5 Million 39.09 Million 40.46 Million 2.63 Million 2.52 Million
Total Non-Current Assets 19.83 Million 33.29 Million 47.49 Million 68.6 Million 49.75 Million 43.29 Million
Net PPE 14.45 Million 17.95 Million 29.02 Million 24.08 Million 26.55 Million 15.94 Million
Good Will And Intangible Assets -1.00 12.64 Million 13.13 Million 13.66 Million 14.2 Million 15.27 Million
Good Will - 10.51 Million 10.51 Million 10.51 Million 10.51 Million 10.51 Million
Intangible Assets - 2.12 Million 2.62 Million 3.14 Million 3.69 Million 4.76 Million
Long-Term Investments 2.78 Million 2 Million 3.9 Million 4.89 Million 6.31 Million 9.4 Million
Tax Assets 1.99 Million 2.31 Million 2.96 Million 3.77 Million 8.07 Million -
Other Non Current Assets 605.31 Thousand -1.63 Million -1.54 Million 22.17 Million -5.39 Million 2.66 Million
Other Assets 1.00 - - - - -
Total Liabilities 55.59 Million 126.17 Million 96.27 Million 78.63 Million 138.54 Million 44.08 Million
Total Current Liabilities 42.57 Million 96.86 Million 65.74 Million 41.7 Million 31.98 Million 35.29 Million
Account Payables 4.64 Million 80.9 Million 24.76 Million 1.46 Million 7.64 Million 11.02 Million
Tax Payables - - - - - -
Short Term Debt 19.17 Million 2.8 Million 2.6 Million 2.32 Million 2.07 Million -
Deferred Revenue - - 21.62 Thousand 46.62 Thousand 124.12 Thousand 257.15 Thousand
Other Current Liabilities 18.74 Million 13.15 Million 38.35 Million 37.86 Million 22.14 Million 24.02 Million
Total Non Current Liabilities 13.02 Million 29.3 Million 30.53 Million 36.92 Million 106.55 Million 8.78 Million
Long-Term Debt 11.03 Million 29.27 Million 30.41 Million 36.71 Million 97.43 Million 11.1 Million
Deferred Revenue Non Current - 16.61 Million 64.36 Thousand 79.21 Thousand 101.56 Thousand 150.79 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - -16.61 Million 14.82 Thousand 95.16 Thousand 8.99 Million -2.49 Million
Other Liabilities - - - - - -
Total Equity 117.34 Million 222.36 Million 399.66 Million 461.14 Million 5.4 Million 87.03 Million
Stock Holders Equity 117.34 Million 222.36 Million 399.66 Million 461.14 Million 3.43 Million 86.93 Million
Common Stock 22.79 Thousand 253.09 Thousand 217.38 Thousand 186.85 Thousand 101.36 Thousand 97.22 Thousand
Retained Earnings -1.62 Billion -1.48 Billion -1.2 Billion -906.19 Million -739.78 Million -620.42 Million
Accumulated other comprehensive income -662.6 Thousand -698.74 Thousand -282.23 Thousand -256.15 Thousand 472.6 Thousand -528.86 Thousand
Common Stock Equity 117.34 Million 222.36 Million 399.66 Million 461.14 Million 3.43 Million 86.93 Million
Capital Lease Obligation 11.03 Million 15.45 Million 18.06 Million 20.39 Million 22.48 Million -
Total Investments 133.76 Million 208.67 Million 334.07 Million 165.8 Million 73.65 Million 66.94 Million
Total Debt 30.2 Million 32.07 Million 33.02 Million 39.04 Million 99.5 Million -
Net Debt 15.89 Million -14.25 Million -38.12 Million -211.67 Million 77.31 Million -23.69 Million

Balance Sheet Charts